Cancer Research Annual Meeting 2010  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jurasz, P.
Right arrow Articles by Radomski, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jurasz, P.
Right arrow Articles by Radomski, M. W.
[Cancer Research 61, 376-382, January 1, 2001]
© 2001 American Association for Cancer Research


Tumor Biology

Matrix Metalloproteinase 2 in Tumor Cell-induced Platelet Aggregation: Regulation by Nitric Oxide1

Paul Jurasz, Grzegorz Sawicki, Marek Duszyk, Jolanta Sawicka, Carlos Miranda, Irvin Mayers and Marek W. Radomski2

Departments of Pharmacology [P. J., G. S., M. W. R.], Physiology [M. D., J. S.], and Medicine [C. M., I. M.], University of Alberta, Edmonton, Alberta, T6G 2H7 Canada

A correlation exists between the ability of tumor cells to aggregate platelets and their tendency to metastasize. Tumor cell-induced platelet aggregation (TCIPA) facilitates the embolization of the vasculature with tumor cells and the formation of metastatic foci. It is well documented that matrix metalloproteinases (MMPs) play an integral part in tumor spread and the metastatic cascade. Therefore, we have examined the role of MMPs during TCIPA and its regulation by nitric oxide (NO) in vitro. Human HT-1080 fibrosarcoma and A549 lung epithelial cancer cells induced TCIPA in a concentration-dependent manner that was monitored by aggregometry. This aggregation resulted in the release of MMP-2 from platelets and cancer cells, as measured by zymography. HT-1080 cells released significantly more MMP-2 than A549 cells and were more efficacious in inducing TCIPA. Inhibition of MMP-2 with phenanthroline (1–1000 µM), a synthetic inhibitor of MMPs, and by neutralizing anti-MMP-2 antibody (10 µg/ml) reduced TCIPA induced by HT-1080 cells. TCIPA was abolished by simultaneous inhibition of platelet function with acetylsalicylic acid (100 µM; thromboxane pathway inhibitor), apyrase (250 µg/ml; ADP pathway inhibitor), and phenanthroline. NO donors such as S-nitroso-n-acetylpenicillamine and S-nitrosoglutathione (both at 0.01–100 µM) inhibited TCIPA and MMP-2 release from platelets and tumor cells. The inhibitory actions of S-nitroso-n-acetylpenicillamine and S-nitrosoglutathione were reversed by 1H-[1,2,4]oxadiazole[4,3]quinoxalin-1-one (0.01–30 µM), a selective inhibitor of the soluble guanylyl cyclase. We conclude that (a) human fibrosarcoma cells aggregate platelets via mechanism(s) that are mediated, in part, by MMP-2; (b) NO inhibits TCIPA, in part, by attenuating the release of MMP-2; and (c) these effects of NO are cGMP-dependent.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
A. Kunita, T. G. Kashima, Y. Morishita, M. Fukayama, Y. Kato, T. Tsuruo, and N. Fujita
The Platelet Aggregation-Inducing Factor Aggrus/Podoplanin Promotes Pulmonary Metastasis
Am. J. Pathol., April 1, 2007; 170(4): 1337 - 1347.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. Alonso-Escolano, C. Medina, K. Cieslik, A. Radomski, P. Jurasz, M. J. Santos-Martinez, T. Jiffar, P. Ruvolo, and M. W. Radomski
Protein Kinase C{delta} Mediates Platelet-Induced Breast Cancer Cell Invasion
J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 373 - 380.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Medina, P. Jurasz, M. J. Santos-Martinez, S. S. Jeong, T. Mitsky, R. Chen, and M. W. Radomski
Platelet Aggregation-Induced by Caco-2 Cells: Regulation by Matrix Metalloproteinase-2 and Adenosine Diphosphate
J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 739 - 745.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. S. Lind
Arginine and Cancer
J. Nutr., October 1, 2004; 134(10): 2837S - 2841S.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Jurasz, D. Alonso, S. Castro-Blanco, F. Murad, and M. W. Radomski
Generation and role of angiostatin in human platelets
Blood, November 1, 2003; 102(9): 3217 - 3223.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. Jurasz, A. W.Y. Chung, A. Radomski, and M. W. Radomski
Nonremodeling Properties of Matrix Metalloproteinases: The Platelet Connection
Circ. Res., May 31, 2002; 90(10): 1041 - 1043.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Jiang, Q. Zhou, M. K. Yu, L. S. Ho, Z. N. Chen, and H. C. Chan
The Involvement of HAb18G/CD147 in Regulation of Store-operated Calcium Entry and Metastasis of Human Hepatoma Cells
J. Biol. Chem., December 7, 2001; 276(50): 46870 - 46877.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.